These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24853574)

  • 21. Reply: To PMID 23021885.
    Di Bona D; Plaia A; Di Lorenzo G
    J Allergy Clin Immunol; 2013 Aug; 132(2):508-10. PubMed ID: 23791511
    [No Abstract]   [Full Text] [Related]  

  • 22. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E; Wahn HU; Didier A; Bachert C
    Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are meta-analysis-based comparisons solid evidence?
    Calderon MA; Andersen JS; Nelson HS
    J Allergy Clin Immunol; 2013 Aug; 132(2):506-8. PubMed ID: 23791515
    [No Abstract]   [Full Text] [Related]  

  • 25. New clinical documentation on ALK grass allergen tablet.
    Bachert C
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():57-60. PubMed ID: 19221621
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergen immunotherapy and mast cells.
    Bradding P
    Clin Exp Allergy; 1999 Nov; 29(11):1445-8. PubMed ID: 10520069
    [No Abstract]   [Full Text] [Related]  

  • 27. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.
    Bonvalet M; Moussu H; Wambre E; Ricarte C; Horiot S; Rimaniol AC; Kwok WW; Horak F; de Beaumont O; Baron-Bodo V; Moingeon P
    Clin Exp Allergy; 2012 Dec; 42(12):1745-55. PubMed ID: 23181790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of allergen immunotherapy.
    Dreborg S
    J Allergy Clin Immunol Pract; 2015; 3(2):267-8. PubMed ID: 25754719
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.
    Ibañez MD; Kaiser F; Knecht R; Armentia A; Schöpfer H; Tholstrup B; Bufe A
    Pediatr Allergy Immunol; 2007 Sep; 18(6):516-22. PubMed ID: 17680910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
    Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
    J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen.
    Martínez-Cañavate Burgos A; Torres-Borrego J; Molina Terán AB; Corzo JL; García BE; Rodríguez Pacheco R; Moreno Aguilar C; Dávila I
    Pediatr Allergy Immunol; 2018 Jun; 29(4):369-374. PubMed ID: 29369414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.
    Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Rivas MF; Ribel M; Durham SR
    J Allergy Clin Immunol; 2006 Aug; 118(2):434-40. PubMed ID: 16890769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial.
    Hellkvist L; Hjalmarsson E; Kumlien Georén S; Karlsson A; Lundkvist K; Winqvist O; Westin U; Cardell LO
    J Allergy Clin Immunol; 2018 Oct; 142(4):1338-1341.e9. PubMed ID: 29908212
    [No Abstract]   [Full Text] [Related]  

  • 37. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.
    Pfaar O; Biedermann T; Klimek L; Sager A; Robinson DS
    Allergy; 2013 Oct; 68(10):1306-13. PubMed ID: 23991896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis.
    Patterson AM; Bonny AE; Shiels WE; Erwin EA
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):168-70. PubMed ID: 26706294
    [No Abstract]   [Full Text] [Related]  

  • 39. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which allergen extract for grass pollen immunotherapy? An in vitro study.
    Marcucci F; Sensi L; Di Cara G; Incorvaia C; Puccinelli P; Scurati S; Frati F
    Immunol Invest; 2010; 39(6):635-44. PubMed ID: 20653430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.